Navigation Links
Comprehensive Safety Tests Published on Ruyan(R) Smoking Alternatives

Tests Conducted in New Zealand and Canada Find Ruyan E-cigarettes Safe;

Results Apply Only to Ruyan Products

MINNEAPOLIS, Oct. 28 /PRNewswire/ -- Ruyan America, Inc., announced today the publication of a report that tested the safety of its electronic smoking alternatives, specifically the nicotine cartridges that produce the smoke-like vapor that users find satisfies their desire for tobacco. The report summary states that the test results confirm that the Ruyan(R) E-cigarette is a safe alternative to smoking, very safe relative to cigarettes and safe in absolute terms on all measurements that were applied. The summary also notes that the report findings refer only and specifically to Ruyan products.

The tests were conducted by Dr. Murray Laugesen of Health New Zealand, Ltd, who also authored the report, and they were performed by seven leading government, university and commercial laboratories in New Zealand and Canada. Ruyan funded the tests and the report, but had no role in the design of the tests or any input with respect to the findings in the report. No completed tests were withheld from the report, which can be viewed in its entirety at

Alexander Chong, CEO of Ruyan America, Inc., commented, "We are pleased to have Dr. Laugesen publish these results, validating the safety of our groundbreaking products and this relatively new product category. But, as the summary states, these results apply only to Ruyan and its products."

Chong went on to note how important these tests are expected to be to distributors, retailers and consumers of the products. "Given how critical ingredients like flavorings and scents are to the overall safety profile of the product, we believe that it's very important for distributors, retailers and consumers to demand this kind of information from anyone claiming the right to market or sell similar products."

About the Products

The Ruyan V-8 E-cigarette is a sophisticated electronic device with patents granted in China and Europe and Patents Pending in the US. The device atomizes purified, liquid nicotine and produces a vapor that, when inhaled, satisfies a smoker's craving for tobacco. The vapor contains none of the harmful chemicals commonly found in traditional cigarette smoke and none of those chemicals considered poisonous or carcinogenic. When and if the vapor is expelled, it does not contain any of the harmful chemicals found in second hand smoke. Cartridges for the Ruyan E-cigarette are available in regular and menthol flavors. The Ruyan V-8 was named the most innovative new product at the 2008 Tobacco Plus Expo.

The Ruyan Vegas E-cigar comes in two varieties, the Classic, which contains 16 mg of nicotine, and the Freestyle, which is nicotine free. Both E-cigars produce a thick, flavorful vapor that satisfies a user's tobacco cravings. The Ruyan Vegas E-cigar was named the most marketable new product at the 2008 Tobacco Plus Expo.

Ruyan smoking alternatives do not produce tobacco smoke or smoke of any kind and, as such, do not violate smoking bans or restrictions. Users have successfully satisfied tobacco urges in all states and in all places where smoking is otherwise restricted.

About the Company

Ruyan America, Inc. is a U.S.-based joint venture partner of Ruyan Holdings, Ltd. of Hong Kong. Mr. Hon Lik, the inventor and patent holder of the E-cigarette and the atomizing technology that is critical to it, the E- cigar and the E-pipe, is the Vice-Chairman of Ruyan Holdings, Ltd. and the Chairman of Ruyan America. These products, varieties of replacement cartridges and their accessories are designed, manufactured and sold for the cigarette alternative/smoking substitution market. They allow smokers to satisfy their tobacco cravings in places and situations where they otherwise cannot smoke by law, regulation or common courtesy. Ruyan is the only manufacturer of E-cigarette pursuant to Mr. Hon's patents and Ruyan America is the only Company providing E-cigarettes, E-cigars, E-pipes, their cartridges and accessories to distributors and retailers in concert with safety test results, product liability insurance, detailed ingredient lists, documentation of proprietary intellectual property and the support of a $4 million Direct Response Television campaign. Information about the company and its products can be found at and the company's DRTV infomercial can be viewed at

Warning: Be advised that nicotine is addictive. The Ruyan products have not been evaluated by the US FDA. They are not intended to be drug products that diagnose, treat, cure or mitigate any disease or condition. Do not use these products if you are under the age of 21; if you are a non-smoker, if you have a demonstrated sensitivity to nicotine or any combination of common inhalants; or if you are pregnant or nursing.

For Additional Information, Please Contact:

William P. Bartkowski, President

Ruyan America, Inc.


SOURCE Ruyan America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
2. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
3. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
7. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
8. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
9. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
10. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
11. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
Post Your Comments:
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... UTRECHT , Nederland, November 26, 2015 ... --> Een nieuwe aanpak combineert ... van gevorderde kanker. ... -->      (Photo: ... van het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... ... sauna parts and accessories. , Sauna accessories help improve the bather experience in ... personality. From basic styles for the purist looking for simplicity in design to ...
(Date:11/25/2015)... ... 26, 2015 , ... Ministers, senior government and UN agencies, ... Centres of Excellence, and public R&D institutions, civil societies and other partners gathered ... 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, ... Two Organizations, One Beat ” campaign. The partnership between the two groups began in ... in MAP International’s cause. , MAP International was founded in 1954 and is an ...
(Date:11/25/2015)... FL (PRWEB) , ... November 25, 2015 , ... ... center, is encouraging people across the country to celebrate their sobriety and show ... people to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... training center for the Narconon network, announced the release of a new cutting edge ... the Narconon organization has been working with drug- and alcohol-addicted individuals with the purpose ...
Breaking Medicine News(10 mins):